REPAGLINIDE
Generic: REPAGLINIDE
Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
REPAGLINIDEActive Substance
2023-03-22Original Approval
REPAGLINIDE is FDA application ANDA207209, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HYPOGLYCAEMIA
794 reports
2
ACUTE KIDNEY INJURY
558 reports
3
DRUG INTERACTION
433 reports
4
DIARRHOEA
384 reports
5
LACTIC ACIDOSIS
368 reports
6
DYSPNOEA
287 reports
7
NAUSEA
266 reports
8
ASTHENIA
260 reports
9
ANAEMIA
248 reports
10
VOMITING
246 reports